Aldesleukin Terminated Phase 1 Trials for Hematopoietic and Lymphoid Cell Neoplasm / Myeloproliferative Disorders / Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01630564Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies